Company profile
OptimizeRx Corp.
NASDAQ: OPRX · Healthcare · Medical - Healthcare Information Services
#339 of 1,418 Healthcare companies by revenue64th-percentile growth
EA Score
72BFH 84DQ 63GM 56SS 69
v0.1 · 65/100 weight · provisional
↑ Piotroski F, 3-yr revenue growth · ↓ growth stability, filing timeliness
Methodology →Revenue TTM
$107.3M
Rev growth YoY (TTM)
+13.8%
Net income (FY)
$5.1M
Employees
133
as of 2026-08-18
Market cap
$158.8M
as of 2026-08-18
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$109.4M$109.4M2025
Net income$5.1M$5.1M2025
Operating income$11.7M$11.7M2025
Total assets$176.9M$176.9M2025
Liabilities$48.6M$48.6M2025
Equity$128.3M$128.3M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY22
FY22
FY23
FY25
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Other Revenue100%
By geography
Not disclosed.
The read
What is OptimizeRx Corp.’s revenue?
OptimizeRx Corp. booked $109.4M in FY2025 revenue, growing 19% year over year — faster than most Healthcare companies we track, at a 4.7% net margin.
Peers · Healthcare
ImmunityBio, Inc.58CAnika Therapeutics, Inc.74BUroGen Pharma Ltd.55CCentury Therapeutics, Inc.48DAuxly Cannabis Group Inc.76B+Theravance Biopharma Inc75B+Neighbors
Middlesex →Key facts
CEOStephen L. Silvestro
SectorHealthcare
IndustryMedical - Healthcare Information Services
HeadquartersWaltham, MA
ExchangeNASDAQ: OPRX
Employees133
IPO date2007-11-28
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.